Studies on prostate cancer have also identified an essential role for UBE2I, and ablation of UBE2I can reverse the immunosuppressive phenotype of tumor-associated macrophages, which is vital for tumor immunity [9]. The gene discussed is UBE2I; the disease is prostate carcinoma.